Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure-Reference-Cited by-同舟云学术

Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure

Published:2008-08-26 Issue:9 Volume:118 Page:926-933
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Piccini Jonathan P.¹,Hernandez Adrian F.¹,Dai David¹,Thomas Kevin L.¹,Lewis William R.¹,Yancy Clyde W.¹,Peterson Eric D.¹,Fonarow Gregg C.¹

Affiliation:

1. From the Duke Clinical Research Institute, Durham, NC (J.P.P., A.F.H., D.D., K.L.T., E.D.P.); MetroHealth Medical Center, Cleveland, Ohio (W.R.L.); Baylor Heart and Vascular Institute, Dallas, Tex (C.W.Y.); and University of California Los Angeles Medical Center, Los Angeles (G.C.F.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference37 articles.

1. National Trends in Outcomes Among Elderly Patients with Heart Failure

2. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: Findings from the National Heart Failure Project

3. Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction

4. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

5. The Adult With Congenital Heart Disease

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between the Affordable Care Act Medicaid Expansion and Receipt of Cardiac Resynchronization Therapy by Race and Ethnicity;Journal of the American Heart Association;2022-10-04

2. Cardiac Resynchronization Therapy in Cardiogenic Shock: A Case-Based Discussion;Cureus;2021-09-21

3. Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction;Current Heart Failure Reports;2021-03-05

4. Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy Patients;Yonsei Medical Journal;2020

5. Comparative Effectiveness Research;Pharmacoepidemiology;2019-10-18